December 15th 2020, 9:00pm
Neeraj Agarwal, MD, a clinician and researcher at the University of Utah Huntsman Cancer Institute, discusses investigational combinations with PARP inhibitors in prostate cancer treatment.
December 12th 2020, 4:00pm
The genes are part of the family that cause cancer cells to grow.
December 11th 2020, 3:30pm
Neeraj Agarwal, MD, of the University of Utah's Huntsman Cancer Institute, discusses ongoing trials of PARP inhibitors as first-line metastatic prostate cancer treatments.
December 5th 2020, 11:15pm
Researchers from the University of California San Francisco published their results in the Journal of Urology.
December 2nd 2020, 9:30pm
Neeraj Agarwal, MD, of the University of Utah's Huntsman Cancer Institute, discusses challenges to progress in getting FDA approval for PARP inhibitors in prostate cancer.
November 26th 2020, 6:30pm
Multiple studies have suggested African American men tend to have more aggressive forms of prostate cancer, but a new study suggests that may not translate to a higher risk of death.
November 24th 2020, 3:00pm
The discovery of a genetic signature that correlates with metastasis in prostate cancer could make it much easier for physicians and patients to choose treatment strategies.
November 21st 2020, 4:10pm
Authors in the Journal of Clinical Oncology discuss hypotheses on the differences in mutations and implications for treatment with PARP inhibitors.
November 20th 2020, 9:48pm
Mounting evidence is supporting the use of poly ADP-ribose polymerase (PARP) inhibitors in prostate cancer, according to a new study.
September 21st 2020, 2:16pm
Having biomarker-driven solutions in prostate cancer is important, because they have been lacking.
